Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kamal Adawi currently holds 75,000 shares of EXAGEN INC. (XGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kamal Adawi has been a net seller of XGN stock. They have purchased $0 and sold $61.6K worth of shares.
Kamal Adawi's most recent insider trade was on Oct 20, 2025, when they sold 75,000 shares at $0.00 per share.
Kamal Adawi serves as Executive at EXAGEN INC. (XGN). They have executed 11 insider transactions totaling $61.6K over their tenure at the company.
Kamal Adawi holds the position of Executive at EXAGEN INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Kamal Adawi has shown a selling trading pattern, with $0 in total purchases and $61.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kamal Adawi was on Mar 1, 2022, when they sold $23.1K worth of XGN shares. This transaction involved 3,241 shares at $7.12 per share.
Kamal Adawi currently owns 75,000 shares of EXAGEN INC. (XGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kamal Adawi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kamal Adawi has 11 Form 4 filings on record as an insider at EXAGEN INC..
Set alerts for Kamal Adawi and 40,000+ other insiders.